CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
- 4 Other acquisition Director acquired 11,068 shares (other)
- 4 Exercise or conversion Director acquired 42,337 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 6,597 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 5,461 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER gave up 5,211 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President, CEO gave up 19,420 shares (to pay taxes)
- 4 Open-market buy Director bought 85,098 shares at an average $12.92 ($1,099,642)
- 4 Planned sale Director sold 10,000 shares at $25.00 ($250,000)
- 4 Planned sale Chief Medical Officer sold 1,500 shares at $38.67 ($58,005)
Page 4 of 15 · 298 filings